Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer

This study reports 2-year survival outcomes among patients with advanced nonprogressive stage IIA to IV lung cancer randomized to symptom monitoring during chemotherapy via web-based patient-reported outcomes vs standard scheduled imaging after treatment to detect symptomatic recurrence.

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Denis, Fabrice, Basch, Ethan, Septans, Anne-Lise, Bennouna, Jaafar, Urban, Thierry, Dueck, Amylou C., Letellier, Christophe
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439676/
https://ncbi.nlm.nih.gov/pubmed/30667494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.18085
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados